398 related articles for article (PubMed ID: 22467239)
21. Knockdown of Cripto-1 inhibits the proliferation, migration, invasion, and angiogenesis in prostate carcinoma cells.
Wu D; Shi Z; Xu H; Chen R; Xue S; Sun X
J Biosci; 2017 Sep; 42(3):405-416. PubMed ID: 29358554
[TBL] [Abstract][Full Text] [Related]
22. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
[TBL] [Abstract][Full Text] [Related]
23. Reactive oxygen species promotes cellular senescence in normal human epidermal keratinocytes through epigenetic regulation of p16(INK4a.).
Sasaki M; Kajiya H; Ozeki S; Okabe K; Ikebe T
Biochem Biophys Res Commun; 2014 Sep; 452(3):622-8. PubMed ID: 25181340
[TBL] [Abstract][Full Text] [Related]
24. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
[TBL] [Abstract][Full Text] [Related]
25. Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients.
Vlenterie M; Hillebrandt-Roeffen MH; Schaars EW; Flucke UE; Fleuren ED; Navis AC; Leenders WP; Versleijen-Jonkers YM; van der Graaf WT
Ann Surg Oncol; 2016 Sep; 23(9):2745-52. PubMed ID: 27334220
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanism of adaphostin-mediated G1 arrest in prostate cancer (PC-3) cells: signaling events mediated by hepatocyte growth factor receptor, c-Met, and p38 MAPK pathways.
Mukhopadhyay I; Sausville EA; Doroshow JH; Roy KK
J Biol Chem; 2006 Dec; 281(49):37330-44. PubMed ID: 16956884
[TBL] [Abstract][Full Text] [Related]
27. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
Dulinska-Litewka J; McCubrey JA; Laidler P
Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
[TBL] [Abstract][Full Text] [Related]
28. p16/MTS1/INK4A suppresses prostate cancer by both pRb dependent and independent pathways.
Steiner MS; Wang Y; Zhang Y; Zhang X; Lu Y
Oncogene; 2000 Mar; 19(10):1297-306. PubMed ID: 10713671
[TBL] [Abstract][Full Text] [Related]
29. The histone demethylase RBP2 Is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells.
Zeng J; Ge Z; Wang L; Li Q; Wang N; Björkholm M; Jia J; Xu D
Gastroenterology; 2010 Mar; 138(3):981-92. PubMed ID: 19850045
[TBL] [Abstract][Full Text] [Related]
30. MEK drives cyclin D1 hyperelevation during geroconversion.
Leontieva OV; Demidenko ZN; Blagosklonny MV
Cell Death Differ; 2013 Sep; 20(9):1241-9. PubMed ID: 23852369
[TBL] [Abstract][Full Text] [Related]
31. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells.
Schmidt M; Fan Z
Oncogene; 2001 Sep; 20(43):6164-71. PubMed ID: 11593424
[TBL] [Abstract][Full Text] [Related]
32. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells.
Jarrard DF; Sarkar S; Shi Y; Yeager TR; Magrane G; Kinoshita H; Nassif N; Meisner L; Newton MA; Waldman FM; Reznikoff CA
Cancer Res; 1999 Jun; 59(12):2957-64. PubMed ID: 10383161
[TBL] [Abstract][Full Text] [Related]
33. Ablation of galectin-3 induces p27(KIP1)-dependent premature senescence without oncogenic stress.
Kim SJ; Lee HW; Gu Kang H; La SH; Choi IJ; Ro JY; Bresalier RS; Song J; Chun KH
Cell Death Differ; 2014 Nov; 21(11):1769-79. PubMed ID: 24971481
[TBL] [Abstract][Full Text] [Related]
34. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells.
Yim D; Singh RP; Agarwal C; Lee S; Chi H; Agarwal R
Cancer Res; 2005 Feb; 65(3):1035-44. PubMed ID: 15705905
[TBL] [Abstract][Full Text] [Related]
35. Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors.
Mir H; Kapur N; Singh R; Sonpavde G; Lillard JW; Singh S
Cell Cycle; 2016; 15(6):819-26. PubMed ID: 27029529
[TBL] [Abstract][Full Text] [Related]
36. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts.
Alcorta DA; Xiong Y; Phelps D; Hannon G; Beach D; Barrett JC
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13742-7. PubMed ID: 8943005
[TBL] [Abstract][Full Text] [Related]
37. RNA interference-mediated cyclooxygenase-2 inhibition prevents prostate cancer cell growth and induces differentiation: modulation of neuronal protein synaptophysin, cyclin D1, and androgen receptor.
Narayanan BA; Narayanan NK; Davis L; Nargi D
Mol Cancer Ther; 2006 May; 5(5):1117-25. PubMed ID: 16731743
[TBL] [Abstract][Full Text] [Related]
38. p21/Cip1 and p27/Kip1 Are essential molecular targets of inositol hexaphosphate for its antitumor efficacy against prostate cancer.
Roy S; Gu M; Ramasamy K; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R
Cancer Res; 2009 Feb; 69(3):1166-73. PubMed ID: 19176374
[TBL] [Abstract][Full Text] [Related]
39. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
40. LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1.
Chen C; Wang Y; Wang S; Liu Y; Zhang J; Xu Y; Zhang Z; Bao W; Wu S
Int J Oncol; 2017 Mar; 50(3):942-952. PubMed ID: 28098854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]